EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, 4SC AG's Enterprise Value is €71.58 Mil.
4SC AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-8.12 Mil. Therefore, 4SC AG's EV-to-EBIT for today is -8.82.
The historical rank and industry rank for 4SC AG's EV-to-EBIT or its related term are showing as below:
FRA:VSC'
s EV-to-EBIT Range Over the Past 10 Years
Min: -15.08 Med: -4.48 Max: -1.78
Current: -8.39
During the past 13 years, the highest EV-to-EBIT of 4SC AG was -1.78. The lowest was -15.08. And the median was -4.48.
FRA:VSC's EV-to-EBIT is ranked worse than 100% of 429
companies
in the Biotechnology industry
Industry Median: 9.84
vs FRA:VSC: -8.39
The historical data trend for 4SC AG's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, 4SC AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4SC AG's EV-to-EBIT Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 4SC AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where 4SC AG's EV-to-EBIT falls into.
4SC AG's current Enterprise Value is €71.58 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4SC AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-8.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4SC AG (FRA:VSC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
4SC AG's Enterprise Value for the quarter that ended in Dec. 2023 was €81.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4SC AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-8.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4SC AG EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of 4SC AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:VSC has been successfully added to your 